Standout Papers

Abelacimab for Prevention of Venous Thromboembolism 2021 2026 2022 2024165
  1. Abelacimab for Prevention of Venous Thromboembolism (2021)
    Peter Verhamme, B. Alexander Yi et al. New England Journal of Medicine

Immediate Impact

27 by Nobel laureates 46 from Science/Nature 78 standout
Sub-graph 1 of 21

Citing Papers

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2025 Standout
Peptide-binding specificity prediction using fine-tuned protein structure prediction networks
2023 StandoutNobel
1 intermediate paper

Works of B. Alexander Yi being referenced

Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa
2021
PDZ domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences
1997
and 1 more

Author Peers

Author Last Decade Papers Cites
B. Alexander Yi 604 291 393 18 1.1k
Nienwen Chow 503 93 147 19 1.4k
Margaret M. Maimone 887 148 223 17 1.2k
Lixin Qi 609 77 66 25 1.2k
Elizabeth Pasnikowski 516 111 380 12 1.0k
Dan Chalothorn 578 118 203 18 959
Michael R. Douglas 585 36 247 25 1.2k
Yoshimitsu Yura 385 137 141 31 926
Patrick Ventura 479 21 174 11 1.1k
Eva Göb 539 75 44 20 1.0k
Soo-Kyung Bae 803 45 143 11 1.4k

All Works

Loading papers...

Rankless by CCL
2026